Journal of Endodontics
Volume 36, Issue 3 , Pages 375-378 , March 2010

Comparative Evaluation of Effect of Preoperative Oral Medication of Ibuprofen and Ketorolac on Anesthetic Efficacy of Inferior Alveolar Nerve Block with Lidocaine in Patients with Irreversible Pulpitis: A Prospective, Double-blind, Randomized Clinical Trial

  • Vivek Aggarwal, MDS

      Affiliations

    • Department of Dental Surgery, Safdarjung Hospital, New Delhi, India
    • Corresponding Author InformationAddress requests for reprints to Dr Vivek Aggarwal, Department of Dental Surgery, Safdarjung Hospital, New Delhi, India.
    • ,
  • Mamta Singla, MDS

      Affiliations

    • Department of Conservative Dentistry and Endodontics, Institute of Dental Sciences and Technology, Modinagar, India
    • ,
  • Debipada Kabi, MDS

      Affiliations

    • Department of Dental Surgery, Safdarjung Hospital, New Delhi, India

References 

  1. Milgrom P. Four dimensions of fear of dental injections. J Am Dent Assoc. 1997;128:756–762
  2. Tortamano IP, Siviero M, Costa CG, Buscariolo IA, Armonia PL. A comparison of the anesthetic efficacy of articaine and lidocaine in patients with irreversible pulpitis. J Endod. 2009;35:165–168
  3. Claffey E, Reader A, Nusstein J, Beck M, Weaver J. Anesthetic efficacy of articaine for inferior alveolar nerve blocks in patients with irreversible pulpitis. J Endod. 2004;30:568–571
  4. Kennedy M, Reader A, Beck M, Weaver J. Anesthetic efficacy of ropivacaine in maxillary anterior infiltration. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91:406–412
  5. Goldberg S, Reader A, Drum M, Nusstein J, Beck M. Comparison of the anesthetic efficacy of the conventional inferior alveolar, Gow-Gates, and Vazirani-Akinosi techniques. J Endod. 2008;34:1306–1311
  6. Cohen HP, Cha BY, Spangberg LS. Endodontic anesthesia in mandibular molars: a clinical study. J Endod. 1993;19:370–373
  7. Childers M, Reader A, Nist R, Beck M, Meyers WJ. Anesthetic efficacy of the periodontal ligament injection after an inferior alveolar nerve block. J Endod. 1996;22:317–320
  8. Dagher BF, Yared GM, Machtou P. The anesthetic efficacy of volumes of lidocaine in inferior alveolar nerve blocks. J Endod. 1997;23:178–180
  9. Vreeland DL, Reader A, Beck M, Meyers W, Weaver J. An evaluation of volumes and concentrations of lidocaine in human inferior alveolar nerve block. J Endod. 1989;15:6–12
  10. Aggarwal V, Jain A, Debipada K. Anesthetic efficacy of supplemental buccal and lingual infiltrations of articaine and lidocaine following an inferior alveolar nerve block in patients with irreversible pulpitis. J Endod. 2009;35:925–929
  11. Potočnik I, Bajrović F. Failure of inferior alveolar nerve block in endodontics. Endod Dent Traumatol. 1999;15:247–251
  12. Rood JP. Some anatomical and physiological causes of failure to achieve mandibular analgesia. Br J Oral Surg. 1977;15:75–82
  13. Parente SA, Anderson RW, Herman WW, Kimbrough WF, Weller RN. Anesthetic efficacy of the supplemental intraosseous injection for teeth with irreversible pulpitis. J Endod. 1998;24:826–828
  14. Hargreaves KM, Keiser K. Local anesthetic failure in endodontics: mechanisms and management. Endod Topics. 2002;1:26–39
  15. Chaudhary P, Martenson ME, Baumann TK. Vanilloid receptor expression and capsaicin excitation of rat dental primary afferent neurons. J Dent Res. 2001;80:1518–1523
  16. Stenholm E, Bongenhielm U, Ahlquist M, Fried K. VRl- and VRL-l-like immunoreactivity in normal and injured trigeminal dental primary sensory neurons of the rat. Acta Odontol Scand. 2002;60:72–79
  17. Goodis HE, Poon A, Hargreaves KM. Tissue pH and temperature regulate pulpal nociceptors. J Dent Res. 2006;85:1046–1049
  18. Renton T, Yiangou Y, Baecker PA, Ford AP, Anand P. Capsaicin receptor VR1 and ATP purinoceptor P2X3 in painful and nonpainful human tooth pulp. J Orofac Pain. 2003;17:245–250
  19. Ferriera SH, Vane JR. New aspects of the mode of action of non-steroidal anti-inflammatory drugs. Annu Rev Pharmacol. 1974;14:57–72
  20. Dray A. Inflammatory mediators of pain. Br J Anaesth. 1995;75:125–131
  21. Lipsky PE. Role of cyclooxygenase-1 and -2 in health and disease. Am J Orthop. 1999;28(suppl 3):8–12
  22. Willoughby DA, Moore AR, Colville-Nash PR. COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease. Lancet. 2000;355:646–648
  23. Uzan A. The unexpected side effects of new nonsteroidal anti-inflammatory drugs. Expert Opin Emerg Drugs. 2005;10:687–688
  24. FitzGerald GA. Coxibs and cardiovascular disease. N Engl J Med. 2004;351:1709–1711
  25. Bresalier RS, Sandler RS, Quan H, et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med. 2005;352:1092–1102
  26. Solomon SD, McMurray JJ, Pfeffer MA, et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med. 2005;352:1071–1080
  27. US Food and Drug Administration. FDA issues public health advisory on Vioxx as its manufacturer voluntarily withdraws the product. FDA News September 30, 2004. Last update: 2007.
  28. Varrassi G, Marinangeli F, Agro F, et al. A double-blinded evaluation of propacetamol versus ketorolac in combination with patient-controlled analgesia morphine: analgesic efficacy and tolerability after gynecologic surgery. Anesth Analg. 1999;88:611–616
  29. McQuay HJ, Poppleton P, Carroll D, et al. Ketorolac and acetaminophen for orthopedic postoperative pain. Clin Pharmacol Ther. 1986;39:89–93
  30. Fletcher D, Negre I, Barbin C, et al. Postoperative analgesia with IV propacetamol and ketoprofen combination after disc surgery. Can J Anaesth. 1997;44:479–485
  31. Mroszczak E, Jung D, Yee J, et al. Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals. Pharmacotherapy. 1990;10:33–49
  32. Modaresi J, Dianat O, Mozayeni MA. The efficacy comparison of ibuprofen, acetaminophen-codeine, and placebo premedication therapy on the depth of anesthesia during treatment of inflamed teeth. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:399–403
  33. Heft MW, Parker SR. An experimental basis for revising the graphic rating scale for pain. Pain. 1984;19:153–161
  34. Abramovitz M, Metters KM. Prostanoid receptors. Ann Rep Med Chem. 1998;33:223–231
  35. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Ann Rev Biochem. 2000;69:145–182
  36. Miyamoto T, Ogino M, Yamamoto S, Hayaishin O. Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. J Biol Chem. 1976;259:2629–2636
  37. Pilbeam CC, Fall PM, Alander CB, Raisz LG. Differential effects of nonsteroidal antiinflammatory drugs on constitutive and inducible prostglandin G/H synthase in cultured bone cells. J Bone Miner Res. 1997;12:1198–1203
  38. Bhattacharya DK, Lecomte M, Rieke CJ, Garavito RM, Smith WL. Involvement of arginine 120, glutamate 524 and tyrosine 355 in the binding of arachidonate and 2- phenylpropionic acid inhibitors to the cyclooxygenase active site of ovine prostglandin endoperoxide H synthase-1. J Biol Chem. 1996;271:2179–2184
  39. Mancini JA, Riendeau D, Falgueyret JP, Vickers PJ, O'Neill GP. Arginine 120 of prostaglandin G/H synthase-1 is required for the inhibition by nonsteroidal anti-inflammatory drugs containing a carboxylic acid moiety. J Biol Chem. 1995;270:29372–29377
  40. Kurumbail R, Stevens A, Gierse J, et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature. 1996;384:644–648
  41. Riendeau D, Charleson S, Cromlish W, Mancini JA, Wong E, Guay J. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays. Can J Phys Pharmacol. 1997;75:1088–1095

PII: S0099-2399(09)01010-3

doi: 10.1016/j.joen.2009.11.010

Journal of Endodontics
Volume 36, Issue 3 , Pages 375-378 , March 2010

Article Tools